FDA Inspection
AstraZeneca ABAstraZeneca AB – FDA Inspection, Sep 26, 2014
Record Details
This FDA Inspection record concerns AstraZeneca AB, with an inspection on September 26, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AstraZeneca AB
- Inspection Date
- September 26, 2014
- Product Type
- Drugs
View Company Profile
ID · fed60938-7fc1-4870-a1b5-e73b1581142f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 897789
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AstraZeneca AB
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca AB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.